Martin J. Colombatto - 29 Jan 2025 Form 4 Insider Report for Catheter Precision, Inc. (VTAK)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
31 Jan 2025, 16:39:51 UTC
Prior SEC filing
10 Jan 2024
Next SEC filing
14 Aug 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Martin J. Colombatto

Key filing fact

Martin J. Colombatto filed Form 4 for Catheter Precision, Inc. (VTAK) on 31 Jan 2025.

Key facts

  • This page summarizes Martin J. Colombatto's Form 4 filing for Catheter Precision, Inc. (VTAK).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 31 Jan 2025, 16:39.

Change

  • Previous filing in this sequence was filed on 10 Jan 2024.
  • Current net transaction value: -$1.2.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

VTAK transaction

Common Stock

Sale

Transaction value
$1.2
Shares
-3
Change %
-100%
Price
$0.4002
Shares after
0
Date
29 Jan 2025
Ownership
see footnote
Footnotes
F1
VTAK holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
57
Date
29 Jan 2025
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

VTAK transaction Derivative

Stock Option

Award

Transaction value
$0
Shares
+100,000
Change %
Price
$0.000000
Shares after
100,000
Date
29 Jan 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
100,000
Exercise price
$0.4200
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Shares held of record by the M Colombatto Trust, for which the reporting person serves as trustee.

Footnote F2

33.33% exercisable on January 29, 2025, 33.33% exercisable on January 29, 2026, and 33.34% exercisable on January 29, 2027.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .